Zymergen Overview
- Founded
- 2013
- Status
- Public
- Employees
- 507
- Stock Symbol
- ZY
- Investments
- 3
- Share Price
- $1.50
- (As of Monday Closing)
Zymergen General Information
Description
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Contact Information
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Other Materials
Other Commercial Products
Stock Exchange
NAS
Primary Office
- 5980 Horton Street
- Suite 105
- Emeryville, CA 94608
- United States
+1 (415) 000-0000
Zymergen Timeline
Zymergen Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.50 | $1.64 | $1.28 - $46.05 | $169M | 103M | 1.12M | -$4.87 |
Zymergen Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 269,035 | 269,035 | ||
| Revenue | 16,743 | 16,743 | 13,284 | 15,419 |
| EBITDA | (326,393) | (326,393) | (233,068) | (223,574) |
| Net Income | (361,785) | (361,785) | (262,194) | (236,803) |
| Total Assets | 522,396 | 522,396 | 304,921 | 227,890 |
| Total Debt | 43,953 | 43,953 | 79,331 | 78,310 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Zymergen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.
Request a free trialZymergen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.
Request a free trialZymergen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based break
Biotechnology
Emeryville, CA
507
As of 2021
00.000
0.000
0000-00-00
00000000
00.000
000000
lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
00000 0000000000 00000000
Seattle, WA
00
As of 0000
000.00
0000
0000-00-00
00000000000
000.00
0000000
t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
Roslin, United Kingdom
0
As of 0000
0000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialZymergen Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arzeda | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Corporation | Roslin, United Kingdom | 0 | 0000000000 | ||
| 000000 00000000 00 | Formerly VC-backed | Boston, MA | 000 | 00.000 | 000000000 | 00.000 |
| 00000 0000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 00000000 | Venture Capital-Backed | Berkeley, CA | 000 | 0000 | 00000000000 | 0000 |
Zymergen Patents
Zymergen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190046916-A1 | Metal-organic framework materials | Pending | 17-Jul-2017 | 000000000 | |
| CA-3029638-C | Chemical substructure search query building and execution | Active | 05-Jul-2016 | 00000000000 | |
| CA-3029638-A1 | Chemical substructure search query building and execution | Granted | 05-Jul-2016 | 00000000000 | |
| US-20180011899-A1 | Complex chemical substructure search query building and execution | Granted | 05-Jul-2016 | ||
| US-10318526-B2 | Complex chemical substructure search query building and execution | Active | 05-Jul-2016 | G06F16/2428 | 0 |
Zymergen Executive Team (20)
Zymergen Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christine Gorjanc | Zymergen | Board Member | 000 0000 |
| Dipchand Nishar | SoftBank Group | Board Member | 000 0000 |
| Jay Flatley | Zymergen | Chief Executive Officer & Chairman | 000 0000 |
| Matthew Ocko | DCVC | Board Member | 000 0000 |
| Rohit Sharma Ph.D | True Ventures | Board Member | 000 0000 |
Zymergen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialZymergen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.
Request a free trialZymergen Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00000000 | 16-May-2021 | 0000000000 | 000.00 | Drug Discovery | |
| 0000000 | 19-Mar-2020 | 0000000000 | 000.00 | Biotechnology | 000000 00 |
| Radiant Genomics | 08-Jan-2018 | Merger/Acquisition | Other Commercial Services | 000000 00 |
Zymergen Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Radiant Genomics | Other Commercial Services | Emeryville, CA | 2012 |
| 0000000 | Biotechnology | Medford, MA | 0000 |